PTX:ASX
Prescient Therapeutics Ltd
A$0.065
0.00%
(0.00) 1D
Sep 10, 4:00:00 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTX...
Mkt. cap
63.47M
Avg. vol.
978.35K
Volume
0.00
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
Mkt. cap
63.47M
Avg. vol.
978.35K
Volume
0.00
52-wk high
A$0.12
52-wk low
A$0.04
EPS
-A$0.01
Shares outstanding
1.05B
No. of employees
3
News stories
From web sources and news partners
Kalkine Media
·
2 days ago
Prescient Therapeutics (ASX:PTX) Extends Share Purchase Plan Deadline to 15 September 2026
TipRanks
·
2 days ago
Prescient Therapeutics Extends Securities Purchase Plan Deadline
Profile
Prescient Therapeutics is a clinical-stage oncology company developing targeted therapies. Prescient's technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Wikipedia
About Prescient Therapeutics Ltd
CEOSteven Yatomi-Clarke
Employees3
FoundedMay 22, 1986
Headquarters-
SectorBiotechnology
Websiteptxtherapeutics.com